A recent post here noted there were more billion-dollar deals than in years past, and the amount was higher than any other year. Along comes the Pfizer-Allergan deal at $160 billion, and we have revised the numbers upward. The key takeaways: 51 billion-dollar-plus deals in 2015 (4% of the 1,282 total), with $549.4 billion spent on those deals (90% of the current $549.4 billion). We’ll have more in the December issue of Health Care M&A News.
Update: Billion-Dollar Health Care Deals, 2015
by Lisa Phillips | Nov 25, 2015 8:00 am | Healthcare Market Updates
Categories
- Ambulatory Surgery Centers
- Behavioral Health Care
- Biotechnology
- CDMO
- CRO
- eHealth
- Healthcare M&A News Leads
- Healthcare Market Updates
- Healthcare Staffing
- Home Health & Hospice
- Hospitals
- Laboratories, MRI & Dialysis
- Long-Term Care
- Managed Care
- Medical Devices
- Medical Office Buildings
- Occupational Health
- Other Services
- Pharmaceuticals
- Physician Medical Groups
- Private Equity
- Rehabilitation
- SPAC
- Specialty Pharmacies
- Uncategorized
- Urgent Care Centers